BIGMAR INC
S-3/A, EX-23.1, 2000-05-31
PHARMACEUTICAL PREPARATIONS
Previous: BIGMAR INC, S-3/A, 2000-05-31
Next: BA MASTER CREDIT CARD TRUST /, 8-K, 2000-05-31



<PAGE>

                                  EXHIBIT 23.1


                    Consent of Independent Public Accountants



The Board of Directors
Bigmar, Inc.


         We consent to the use of our report incorporated herein by reference
and to the reference to our firm under the heading "Experts" in the
Prospectus and Registration Statement on Form S-3, as amended. Our report
dated March 16, 2000 contains an explanatory paragraph that states that the
Company has suffered recurring losses from operations and anticipates it will
require additional financing in order to fund its operations during 2001,
which raise substantial doubt about its ability to continue as a going
concern. The consolidated financial statements do not include any adjustments
that might result from the outcome of that uncertainty.


/s/  KPMG LLP

Columbus, Ohio

May 31, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission